A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Acta Medica Medianae
Development of pharmaceutical technology and occurence of different dosage forms and routes of administration of the same, well-known drugs leaded to greater role of bioequivalence testing. In this review, we would like to emphasize some aspects of bioequivalence testing between brand name and generic drug forms in both in vitro and in vivo conditions. We also consider important to present some examples of negative bioequivalence from marketed products in the past, together with the seriousdoaj:a0b846a2570643759da6b2b27584cf2f fatcat:oflg3fexcrh3dapjudnsks7z6a